This text is a result of machine translation.
Special representative of the Russian President: Russia will realize technological sovereignty within 10 to 20 years
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Three departments: incorporate the construction of public fitness facilities in rural areas into the five-year action plan for building fitness facilities in various regions
Goethe shares flash crash limit Securities Department: the company's operation is stable, and the expectation for the second quarter has not been adjusted
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
American officials: the United States plans to expand its diplomatic presence in the Indian Pacific Region
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
How Can Solar Companies Seize Opportunities in the Post-Subsidy Era?
Yesterday 05:23 PM
Mexicans Who Can’t Afford Tacos Flock to Chinese Restaurants
Oct 08, 2024 11:11 AM